Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits QuantWave Price Target Forecast with Profit of 24.59%

May 01, 2023
ELI LILLY AND COMPANY (LLY) recently achieved the price target forecast set by QuantWave with a profitable return of 24.59%. The forecast signal was issued on July 22, 2022, at a price of $320.27, indicating a long position projection. This forecast came to fruition on May 1, 2023, when the stock reached $399.03.

This successful prediction showcases the accuracy and reliability of QuantWave's analytics in guiding investors towards profitable opportunities. The market analysis leading up to this forecast considered various factors such as the company's financial performance, industry trends, and macroeconomic indicators. The achievement of the price target highlights the effectiveness of QuantWave's algorithm in identifying potential stock movements.

QuantWave, an automated forecasting platform, provides users with predictions for a wide range of stocks, offering the potential for profitable returns. Investors can leverage QuantWave's insights to make informed decisions and capitalize on market opportunities. For those interested in delving deeper into investment strategies, QuantSchool offers a comprehensive professional framework for utilizing QuantWave's forecasting system. By understanding the key principles outlined in QuantSchool, investors can generate consistent income using QuantWave's predictive analytics.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

BTC-USDNovember 10, 2023BITCOIN USD Hits Price Target Forecast with 84.44% Profit  ~1 min.

On July 4, 2022, QuantWave issued a long signal for BITCOIN USD when the price was at 20231.26 $....

CFApril 8, 2025QuantWave Hits Bullseye with CF INDUSTRIES HOLDINGS, INC Forecast, Profiting 11.66%  ~1 min.

QuantWave, the automated forecasting platform, has once again proven its accuracy with the recent achievement of its price target forecast for CF INDUSTRIES HOLDINGS, INC....

ALBApril 4, 2025ALBEMARLE CORPORATION Hits Price Target Forecast, Yielding 29.54% Profit  ~1 min.

On August 20, 2024, QuantWave issued a short forecast signal for ALBEMARLE CORPORATION with a price of 83.04 $. The forecast was successfully achieved on April 4, 2025, when the stock reached 58....

BTC-USDDecember 3, 2023BITCOIN USD Hits Forecast Price Target with 47.95% Profit  ~1 min.

QuantWave, a leading automated forecasting platform, achieved a significant milestone as its price target forecast for BITCOIN USD was successfully reached on December 3, 2023....

SLBApril 7, 2025SCHLUMBERGER LIMITED Hits Forecast Price Target with 18.99% Profit  ~1 min.

On February 27, 2025, QuantWave's forecast signal for SCHLUMBERGER LIMITED indicated a short direction with a price of 40.57 $....